Cancer of the thyroid gland is cancer that occurs most often in young people. What forms this cancer? What are the signs that can alert? Update on thyroid cancer.
-Thyroid: where is it placed? What is it?
-What are the signs that may indicate thyroid cancer?
-What are the risk factors of thyroid cancer?
-What is the treatment of thyroid cancer?
Thyroid: where is it placed? What is it?
The thyroid is a small gland at the base of the neck that secretes thyroid hormones rich in iodine, also known as T4 thyroxin and triiodothyronine (T3), which are involved in the functioning of most organs. Continue reading “WHAT ARE THE SIGNS OF A THYROID CANCER?”
Relatively infrequent, the ovarian cancer is the 4th largest gynecological cancers. Often it is discovered late because it develops slowly and without specific symptoms. It was then that may be of poor prognosis, hence the need for regular gynecological monitoring.
1.What are the symptoms of ovarian cancer?
2.Risk factors of ovarian cancer
3.The diagnosis and treatment
One ovary may be affected, or both. In 80% of cases, tumors of the ovary develop from cells on the surface of the ovary (epithelial cancers). In most other cancers, tumors are derived from germ cells (which develop from cells producing eggs).
What are the symptoms of ovarian cancer?
Early diagnosis of ovarian cancer is difficult because symptoms are nonspecific. Thus it is often detected late, when it extends to adjacent organs (fallopian tubes, uterus) or to other tissues (stomach, liver, intestine). Continue reading “THE OVARIAN CANCER IN 3 POINTS”
A recent study, combined hormone replacement therapy for menopause, continuous take, does not increase the risk of uterine cancer. Instead, it would seem protective.
1.The advantages of hormone replacement therapy
At the time of menopause, hormone replacement therapy based on estrogen is prescribed to combat the risks of estrogen deficiency (both short term on the symptoms of menopause such as hot flashes , on the long term aging the skin , arteries, etc..). Estrogens promote the proliferation of endometrial cells, it is recommended to associate with a progestin, which compensates this effect. Thus, the risk of uterine cancer is not increased with the treatment, called “combined” combining estrogen and progesterone. There are two types: continuous or discontinuous engagement (14 days per cycle).
A team of researchers studied the effects of continuous combined hormone therapy in postmenopausal women with a cancer of the endometrial (uterine lining) by compared to a control population. Women who received continuous treatment, compared to patients not following any treatment, have a risk of uterine cancer by 0.6. This risk is 0.4 compared to intermittent hormone therapy. Taking continuous hormone substitutive over several years does not increase the risk of endometrial cancer, rather it tends to decrease, showing that combined form (estrogen and progesterone) is continuous in the most advantageous. Continue reading “HORMONE REPLACEMENT THERAPY CONTINUOUSLY DECREASES THE RISK OF UTERINE CANCER”